Financials in GBp. Standardized financial statements.
A compact view of how Surgical Innovations Group plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £11.60M | £11.95M | £12.01M | £11.34M | £9.13M | £6.33M | £10.73M | £10.97M | £8.75M | £6.09M |
| Revenue Growth? | -2.9% | -0.6% | +5.9% | +24.3% | +44.2% | -41.0% | -2.2% | +25.3% | +43.7% | 0.0% |
| Cost of Revenue? | £8.55M | £8.51M | £8.57M | £7.42M | £6.00M | £5.06M | £6.40M | £6.30M | £5.03M | £4.03M |
| Gross Profit? | £3.05M | £3.44M | £3.45M | £3.92M | £3.13M | £1.27M | £4.33M | £4.67M | £3.72M | £2.06M |
| Gross Margin? | +26.3% | +28.8% | +28.7% | +34.6% | +34.3% | +20.1% | +40.4% | +42.6% | +42.5% | +33.8% |
| Operating Expenses? | £3.78M | £4.23M | £4.04M | £3.88M | £3.61M | £5.06M | £6.82M | £4.33M | £3.16M | £1.59M |
| Operating Income? | -£731,000 | -£791,000 | -£596,000 | £41,000 | -£480,000 | -£3.79M | -£2.43M | £620,000 | £581,000 | £469,000 |
| EBITDA? | -£73,000 | -£99,000 | £161,000 | £628,000 | £247,000 | -£2.20M | -£1.17M | £2.24M | £1.99M | £1.41M |
| Income Before Tax | -£944,000 | -£2.05M | -£728,000 | -£57,000 | -£585,000 | -£3.31M | -£2.60M | £515,000 | £542,000 | £278,000 |
| Income Tax Expense | -£49,000 | -£107,000 | -£219,000 | -£321,000 | -£129,000 | -£31,000 | £23,000 | -£210,000 | -£84,000 | -£438,000 |
| Net Income? | -£895,000 | -£1.94M | -£509,000 | £264,000 | -£456,000 | -£3.28M | -£2.62M | £725,000 | £626,000 | £716,000 |
| EPS? | £-0.00 | £-0.00 | £-0.00 | £0.00 | £-0.00 | £-0.00 | £-0.00 | £0.00 | £0.00 | £0.00 |
| Diluted EPS? | £-0.00 | £-0.00 | £-0.00 | £0.00 | £-0.00 | £-0.00 | £-0.00 | £0.00 | £0.00 | £0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality